1Phillips JK. Pathogenesis of hypertension in renal failure: role of the sympathetic nervous system and renal afferents. Clin Exp Pharmacol Physiol, 2005, 32:415 -418.
2Hansen J, Jacobsen TN, Victor RG. Is nitric oxide involved in the tonic inhibition of central sympathetic outflow in humans? Hypertension, 1994, 24:439 -444.
3Krukoff TL. Central actions of nitric oxide in regulation of autonomic functions. Brain Res Brain Res Rev, 1999, 30:52-65.
4Fujii T, Kurata H, Takaoka M, et al. The role of Renal sympathetic nervous system in the pathogenesis of Ischemic acute renal failure. Eur J Pharmacol, 2003, 481:241 -248.
5Endemann DH,Wolf K,Boeger CA,et al. Adrenal aldosterone biosynthesis is elevated in a model of chronic renal failure: Role of local adrenal renin-angiotensin system. Nephron Physiol, 2004, 97:37 -44.
6Vonend O, Marsalek P, Russ H, et al. Moxonidine treatment of hypertensive patients with advanced renal failure. J Hypertens,2003, 21 (9) :1625 - 1626.
7Miyamoto H, Masai M, Onuma I, et al. Pratosartan, an angiotensin Ⅱ receptor blocker, suppresses sympathetic nerve hyperactivity evaluated by wavelet analyze system in conscious hypertensive rats. J Hypertens, 2006, 24: 315.
8DiBona GF, Kopp UC, Neural control of renal function. Physiol Rev, 1997,77:75 - 197.
9Campese VM. A new model of neurogenic hypertension caused by renal injury: pathophysiology and therapeutic implications. Clin Exp Nephrol, 2003,7 : 167 - 171.
10Joles JA, Koomans HA. Causes and consequence of increased sympathetic activity in renal disease, hypertension, 2004, 43: 699- 706.
